Decoy Therapeutics (DCOY) Gross Margin (2016 - 2019)
Decoy Therapeutics (DCOY) posted quarterly Gross Margin of 95.96% for Q2 2019, up 6926.0% year-over-year from 1.37% in Q2 2018, and up 3.43% quarter-over-quarter from 92.78% in Q1 2019.
Decoy Therapeutics (DCOY) Gross Margin (2016 - 2019) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Gross Margin for 4 consecutive years, with 95.96% the latest figure, recorded in Q2 2019.
- In Q2 2019, Gross Margin rose 6926.0% year-over-year to 95.96%; the TTM figure through Jun 2019 stood at 88.53% (up 3726.0% YoY), while the FY2018 annual figure was 77.93%, up 1767.0% from the prior year.
- Gross Margin improved to 95.96% in Q2 2019 per DCOY's latest filing, from 92.78% in the prior quarter.
- Across five years, Gross Margin topped out at 95.96% in Q2 2019 and bottomed at 1.56% in Q2 2016.
- Historically, Gross Margin has averaged 58.66% across 4 years, with a median of 56.69% in 2017.
- Annual changes were most pronounced in 2018 — Gross Margin plunged 2998 bps — and 2019, when it surged 6926 bps.
- Decoy Therapeutics' Gross Margin stood at 54.07% in 2016, then slipped by 2 bps to 52.85% in 2017, then rose by 2 bps to 54.05% in 2018, then soared by 78 bps to 95.96% in 2019.
- Business Quant data shows DCOY's Gross Margin at 95.96% in Q2 2019, 92.78% in Q1 2019, and 54.05% in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 95.96% |
| Mar 31, 2019 | 92.78% |
| Dec 31, 2018 | 54.05% |
| Sep 30, 2018 | 80.40% |
| Jun 30, 2018 | 26.70% |
| Mar 31, 2018 | 53.00% |
| Dec 31, 2017 | 52.85% |
| Sep 30, 2017 | 64.03% |
| Jun 30, 2017 | 56.69% |
| Mar 31, 2017 | 67.39% |
| Dec 31, 2016 | 54.07% |
| Sep 30, 2016 | 63.09% |
| Jun 30, 2016 | 1.56% |